On Demand Webinar

Functional Screening of Patient-Derived Organoids Using High-Content Imaging

Watch our exclusive webinar and discover how you can revolutionize your cancer research and drug discovery efforts using patient-derived organoids and high-content imaging.

Watch Now

You'll learn about:

• Expert guidance on selecting the most suitable in vitro and in vivo models for your specific research needs, optimizing drug screening, and conducting efficient efficacy testing. 
  
  
• OrganoidBase^TM - our free, extensive resource of patient data, which includes IC₅₀ values, light microscopy, histopathology, and genomic information. 
  
  
• Case studies that demonstrate the power of functional screening using high-content imaging on a colorectal cancer PDO biobank. Witness how this approach can drive impactful discoveries and advance your research objectives.
  
  
• Cutting-edge IO assays with organoids, enabling flexible immune cell profiling and treatment evaluation. These advanced techniques can provide deeper insights into the efficacy and mechanisms of immunotherapies.

Watch Now!

About The Presenter:

Sumithra Urs, PhD, Director, Scientific Engagement

Sumithra’s post-doctoral work on role of Notch signalling in human breast cancer fueled her interest in focusing on oncology and modelling.  Prior to joining industry, she was at the University of Michigan, Translational Oncology Program, focused on pancreatic cancer research and establishing PDX models and 3D microtumors for drug screening. Sumi has more than six years of preclinical oncology experience using syngeneic mice tumor models, xenografts, and 3D platforms.  As a subject matter expert in preclinical oncology, her experience includes pharmacology, immuno-oncology, CAR T/adoptive cell therapy, radiotherapy, and combination therapies. Sumi’s academic training as well as CRO experience in the preclinical space helps her understand client’s requirements and offer suggestions on model selection and study design specific to enable drug screening, efficacy and help in advancing to clinical trials.